279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion
12 clinical trials,   23 drugs   (DrugBank: 9 drugs),   3 drug target genes,   103 drug target pathways

Searched query = "Huge venous malformation with cervical, oral and pharyngeal diffuse lesion", "Huge venous malformation", "Venous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04409145
(ClinicalTrials.gov)
October 1, 202011/5/2020First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene MutationsOpen-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic MutationsVenous Malformation;Lymphatic Malformation;Venolymphatic MalformationDrug: VT30Venthera, Inc.NULLRecruiting18 Years60 YearsAll51Phase 1;Phase 2United States